ROBOCYTE Trademark

Trademark Overview

On Friday, February 12, 2021, a trademark application was filed for ROBOCYTE with the United States Patent and Trademark Office. The USPTO has given the ROBOCYTE trademark a serial number of 90527075. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Thursday, September 14, 2023. This trademark is owned by Chemelion Inc.. The ROBOCYTE trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Medical nanorobots for targeted drug delivery, treating cancer, and treating other medical and physiological conditions in the nature of Vascular, Infectious, Neoplastic, Degenerative, Iatrogenic/intoxication, Congenital, Autoimmune, Traumatic, Endocrine/metabolic diseases; Medical nanorobots for targeted drug delivery, treating cancer and for the purpose of improving human health and wellbeing; Surgical nanorobots

Advanced product research in the field of artificial intelligence; Research in the field of artificial intelligence; Product design and development in the field of medical nanorobots
robocyte

General Information

Serial Number90527075
Word MarkROBOCYTE
Filing DateFriday, February 12, 2021
Status600 - ABANDONED - INCOMPLETE RESPONSE
Status DateThursday, September 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical nanorobots for targeted drug delivery, treating cancer, and treating other medical and physiological conditions in the nature of Vascular, Infectious, Neoplastic, Degenerative, Iatrogenic/intoxication, Congenital, Autoimmune, Traumatic, Endocrine/metabolic diseases; Medical nanorobots for targeted drug delivery, treating cancer and for the purpose of improving human health and wellbeing; Surgical nanorobots
Goods and ServicesAdvanced product research in the field of artificial intelligence; Research in the field of artificial intelligence; Product design and development in the field of medical nanorobots

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, September 9, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeP - NOT AVAILABLE
Class Status DateThursday, September 9, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameChemelion Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Trademark Events

Event DateEvent Description
Thursday, September 14, 2023ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Thursday, September 14, 2023ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Thursday, September 14, 2023ABANDONMENT - INCOMPLETE RESPONSE
Wednesday, May 31, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, May 31, 2023CONTINUATION OF FINAL REFUSAL E-MAILED
Wednesday, May 31, 2023ACTION CONTINUING A FINAL - COMPLETED
Tuesday, February 14, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, February 14, 2023CONTINUATION OF FINAL REFUSAL E-MAILED
Tuesday, February 14, 2023ACTION CONTINUING A FINAL - COMPLETED
Monday, January 9, 2023NOTICE OF REVIVAL - E-MAILED
Monday, January 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2023ASSIGNED TO LIE
Monday, January 9, 2023PETITION GRANTED - RESPONSE RECEIVED
Monday, December 19, 2022ASSIGNED TO PETITION STAFF
Tuesday, November 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 22, 2022TEAS PETITION TO REVIVE RECEIVED
Thursday, September 22, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, September 22, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, September 22, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 17, 2022ASSIGNED TO EXAMINER
Thursday, March 10, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 10, 2022FINAL REFUSAL E-MAILED
Thursday, March 10, 2022FINAL REFUSAL WRITTEN
Thursday, March 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 9, 2021NON-FINAL ACTION E-MAILED
Thursday, September 9, 2021NON-FINAL ACTION WRITTEN
Thursday, September 9, 2021REMOVED FROM TEAS PLUS
Thursday, September 9, 2021ASSIGNED TO EXAMINER
Monday, May 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 16, 2021NEW APPLICATION ENTERED

Related Keywords

robocyte medical nanorobots field treating product intelligence research artificial drug targeted